Home › Johnson & Johnson edges Street views with weak 2Q
 

Keywords :   


Johnson & Johnson edges Street views with weak 2Q

2015-07-14 22:18:25| Biotech - Topix.net

Johnson & Johnson's recovering U.S. consumer health business, following years of recalls that kept Tylenol, Motrin and other marque brands off store shelves, put a much-needed Band-Aid over a rough second quarter. Sales dropped across every other business segment, unusual for the world's top maker of health care products, which also sells prescription medicines and medical devices.

Tags: street views johnson weak

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 26
05.07Hurricane Beryl Wind Speed Probabilities Number 26
05.07Hurricane Beryl Forecast Advisory Number 26
05.07Hurricane Beryl Public Advisory Number 26
05.07Tropical Storm Aletta Graphics
05.07Tropical Storm Aletta Wind Speed Probabilities Number 3
05.07Summary for Tropical Storm Aletta (EP1/EP012024)
More »